Gilead Sciences, Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Gilead Sciences, Inc.

Patent Number:
Title:
Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase
Opposition Date:
Jan 7, 2021
Patent Number:
Title:
Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity
Opposition Date:
Feb 4, 2020
Patent Number:
Title:
Chemical Compounds
Opposition Date:
Dec 17, 2018
Patent Number:
Title:
Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity
Opposition Date:
Dec 6, 2018

Latest patents of Gilead Sciences, Inc. opposed by its competitors

Patent:
Grant Date:
Aug 30, 2023
Title:
Non-Coding Immunomodulatory Dna Construct
Oppositions:
1
Patent:
Grant Date:
Mar 22, 2023
Title:
Pharmaceutical Formulations
Oppositions:
1
Patent:
Grant Date:
Mar 1, 2023
Title:
Pharmaceutical Formulations
Oppositions:
1
Patent:
Grant Date:
Aug 12, 2020
Title:
Methods For Treating Hcv
Oppositions:
1
Patent:
Grant Date:
Jan 8, 2020
Title:
Modulators Of Pharmacokinetic Properties Of Therapeutics
Oppositions:
3
Patent:
Grant Date:
Aug 28, 2019
Title:
Therapeutic Compositions For Treatment Of Human Immunodeficiency Virus
Oppositions:
3
Patent:
Grant Date:
Jan 10, 2018
Title:
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5]Pyrazino [2, 1-B]Oxazepin-8-Olate
Oppositions:
1
Patent:
Grant Date:
Apr 19, 2017
Title:
Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making Same
Oppositions:
3
Patent:
Grant Date:
Mar 29, 2017
Title:
Compositions And Methods Of Treating Pulmonary Hypertension
Oppositions:
6

Competitors of Gilead Sciences, Inc.

COOKE, RICHARD

SHIONOGI & CO., LTD

STADA ARZNEIMITTEL AG

Want to track Gilead Sciences, Inc.?

Feel free to send us a message here and we will get back to you